BioLife Solutions receives Nasdaq delisting notice for delayed 10-K filing

BIOLIFE SOLUTIONS INC

Received Nasdaq notice on March 17, 2022 for failure to timely file 2021 10-K.
Has until May 16, 2022 to submit a plan to regain compliance.
If plan accepted, Nasdaq may grant extension until September 12, 2022.
CFO states Form 10-K expected to be filed no later than March 31, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.